Altris AI

The OCT scan below reveals a characteristic indicator of diabetic retinopathy (DR): a microaneurysm. ?? See how AI detects DR on real scans in our Demo: https://demo.altris.ai/ Microaneurysms appear as small, distinct, oval-shaped, hyperreflective, walled structures. This structural weakness in the vessel wall causes fluid leakage, resulting in edema.

Join the Altris AI team at FLORetina ICOOR2024! Contact us to book a meeting with Mark Braddon on December 5th or 6th to discuss how our AI-powered OCT analysis platform can elevate your practice, efficiently detect, measure, and track 70+ retinal pathologies and biomarkers, including nAMD, AMD, GA, DR, and DME. ? When: December 5-6 ? Where: Florence, Fortezza da Basso

Altris AI is on the Venture Landscape Map of Chicago as one of the innovators in healthtech. Yet, it is unique in building an AI-powered OCT scan analysis platform as a decision-making support tool for eye care professionals.

Differentiating between an OCT scan of a healthy eye vs. a pathological one is a practical skill gained after years of practice. See how AI detects, identifies, and tracks biomarkers/ pathologies in the Demo:https://demo.altris.ai/ Altris AI Chief Medical Officer, Maria Znamenska, MD, PhD speaks about the basic concepts of effective OCT scan analysis: ? contrast between light and dark areas ?structure ?thickness ?reflectivity ?integrity ?definition ?displacement Explore the scans with wet and dry AMD, DR, CRVO analyzed by Altris AI https://lnkd.in/dgjZbuSQ

November is a Diabetes and Diabetic Eye Disease Awareness Month. This month is a critical reminder of the alarming increase in the number of people with diabetes. Eye care professionals are on the front lines in addressing a leading cause of blindness stemming from a condition strongly connected to diabetes — Diabetic Retinopathy (DR). ? See how AI detects DR on OCT scans in our Demo: https://demo.altris.ai/ One reason DR causes such high rates of blindness lies in its silent progression, with clinically visible changes appearing too late. Regular OCT exams, especially for patients with diabetes, help detect the early stages of DR and allow for safer management. ? AI for OCT not only assists in identifying the earliest and most subtle signs of DR but is also a perfect tool for precisely tracking pathological changes and treatment results over time.

The American Academy of Ophthalmology has designated November as Diabetic Eye Disease Awareness Month. It's a great reminder that Diabetic retinopathy (DR) is the leading cause of blindness in working-age adults. A recent meta-analysis estimated that the current global prevalence of DR is about 103 million people, which is projected to rise further to 161 million by 2045. The DR pandemic is a pressing global problem that demands the attention of eye care professionals worldwide. Altris AI is committed to supporting eye care professionals in the fight against DR. Our AI-powered OCT analysis platform can detect DR earlier and more efficiently. The video below demonstrates how the platform detects the slightest changes on a scan, measures them quantitatively, and is a perfect tool for tracking treatment/pathology progression. By providing eye care professionals with the most advanced instruments, Altris AI empowers them to deliver the best care to their patients. Early detection and patient education offer a chance to preserve vision and quality of life.

? Support in diagnostic decision-making & education of patients. These are some of the values our clients see in Altris AI. Thank you, Mohamed Ayyaz Kasmani for sharing your feedback with the Altris AI team.

Take a look at a part of the workflow within the Altris AI platform, examining a scan with the Pathology Detection module. This video from our Demo account ? https://demo.altris.ai/ shows a case of detected dry AMD and GA on OCT. You can see how the AI has highlighted biomarkers and our recent feature: drusen count.

For optometrists, practice growth often means balancing exceptional patient care with savvy business strategies. We've collected some optometry practices that are leveraging innovative approaches to boost patient engagement and practice efficiency. Here are key growth strategies for 2024-2025: ? AI for OCT Analysis: Enhancing diagnostics with OCT analysis.The strategy chosen by William Fruchtman ? Dry Eye Specialization: Advanced tools for diagnostics and targeted treatments by Dr. Shane Swatts ?Aesthetic Optometry: Adding profitable, patient-centered services by Dr. Janelle Davison ?Patient-Centered Care: Integrating virtual showrooms for eyewear by Melissa Richard ? Concentration on glaucoma management. The strategy was chosen by James Deom O.D, M.P.H Check out the full article on Altris AI for more insights! https://lnkd.in/d8SQWDpu

3 busy days at American Academy of Ophthalmology are over for the Altris AI. I was happy to meet everyone and talk about the future of the eye care. Artificial Intelligence (AI) is definitely a huge part of it, that is for sure.Let's meet in 2025!